ED has become more prominent over the last several decades, especially in younger adults, and represents a mounting health concern causing a significant effect on men’s quality of life,” said Jed Kaminetsky, MD, FACS, Urologist, Director of Research, Integrated Medical Professionals, a Division of Solaris Health, and the clinical study lead investigator. “Many patients in my practice are seeking better results from their ED treatment. Read about the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED) study.
Hundreds of reviews rate us 5 out of 5 stars!
